[1] | Gioacchino, L., 2005, Meta-analysis in medical research: The handbook for the understanding and practice of meta-analysis, BMJ Books, ISBN: 978-1-4051-2733-2. |
[2] | Sanchez-Meca, J., and Marin-Martinez, F., 2010, Meta-analysis in psychological research, International Journal of Psychological Research, 3(1), pp. 151-163. |
[3] | Cai, T., Parast, L., and Ryan, L., 2010, Meta-analysis for rare events, Stat. Med. Journal, 29(20), pp.2078–2089. doi:10.1002/sim.3964. |
[4] | Friede, T., Rover, C., Wandel, S., and Neuenschwander, B., 2016, Meta-analysis of few small studies in orphan diseases, Research Synthesis Methods, DOI: 10.1002/jrsm.1217. |
[5] | Lane, P., 2011, Meta-analysis of incidence of rare events, Statistical Methods in Medical Research Journal, Vol. 22(2), pp. 117-132. |
[6] | DerSimonian, R., and Laird, N., 1986, Meta-analysis in clinical trials, Controlled Clinical Trials Journal, Vol. 7, pp. 177–188. |
[7] | Lee, C., Cook, S., Lee, J., and Han, B., 2016, Comparison of two meta-analysis methods: inverse-variance-weighted average and weighted sum of Z-scores, Genomics Information Journal, 14(4), pp. 173-180. doi.org/10.5808/GI.2016.14.4.173. |
[8] | Moher, D., Liberati, A., Tetzlaff, J., and Altman, D., 2007, PRISMA group (2009) preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097. |
[9] | DerSimonian, R., and Laird, N., 2015, Meta-analysis in clinical trials revisited, Contemporary Clinical Trials, 45(0 0), pp. 139–145. doi: 10.1016/j.cct.2015.09.002. |
[10] | Tobias, A., 1999, Assessing the influence of single study in the meta-analysis estimate, Stata Technical Bulletin, 8(47), pp.15-17. |
[11] | Begg, C., and Mazumdar, M., 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics Journal, 50(4), pp. 1088-101. |
[12] | Egger, M., Davey, S., Schneider, M., and Minder, C., 1997, Bias in meta-analysis detected by a simple, Graphical Test, BMJ, 315(7109), pp. 629-34. |
[13] | Higgins, J., and Thompson, S., 2002, Quantifying heterogeneity in a meta-analysis, Statistics in Medicine, 21(11), pp.1539–1558. DOI: 10.1002/sim.1186. |
[14] | Bouhnik, A., Preau, M., Vincent, E., Carrieri, M., Gallais, H., Lepeu, G., Gastaut, J. A., Moatti, J. P., and Spire, B., 2005, Depression and clinical progression in HIV- infected drug users treated with highly active antiretroviral therapy, Journal of Antiviral Therapy, 10(1), pp.53-61. |
[15] | Antelman, G., Kaaya, S., Wei, R., Mbwambo, J., and Msamanga, I., 2007, Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania, Journal of Acquired Immune Deficiency Syndromes, 44(4), pp. 470-77. |
[16] | Lesserman J, Pence BW, Whetten K, Mugavero MJ, Thielman NM, Swartz MS, Stanql D. Relation of Lifetime trauma and depressive symptoms to mortality in HIV, American Journal of Psyciatry, Vol. 164, pp. 1707-13. |
[17] | Anastos, K., Schneider, F., Grange, S., Minkoff, H., and Greenblatt, R., 2005, The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women, Journal of Acquired Immune Deficiency Syndromes, 39(5), pp. 537-44. |
[18] | Mugavero, M., Pence, B., Whetten, K., Lesserman, J., Swartz, M., Stanql, D., and Thielman, N. M., 2007, Predictors of AIDS- related morbidity and mortality in a southern U. S. cohort, AIDS Patient Care STDS, 21(9), pp. 681-90. |
[19] | Tsai, Y., Brian, T., Chan, L., Yap, B., and Haberer, L., 2014, Mental health and mortality in an HIV treatment cohort in rural Uganda Alexander C., Topics in Antiviral Medicine Journal, vol. 22 (e-1):568. #1068. Available https://www.iasusa.org/sites/default/files/tam/apr_2014.pdf. |
[20] | Lima, V., Geller, J., Bangsberg, D., Patterson, T., and Daniel, M., 2007, The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART, AIDS Journal, 21(9), pp.1175-83. |
[21] | Nissen, S., and Wolski, K., 2007, Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes, New England Journal of Medicine, Vol. 356, pp. 2457–2471. |
[22] | Bracken, M., 2007, Rosiglitazone and cardiovascular risk, New England Journal of Medicine, Vol.357, pp.937–938. |
[23] | Yakasai, A. M., Muhammad. H., Mahmood, M., Musa, B., and Muktar, A., 2015, Adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria: A systematic review and meta- analysis, Hindawi Publishing Corporation, Journal of Tropical Medicine, Volume 2015, Article ID 189232, 11 pages. http://dx.doi.org/10.1155/2015/189232. |
[24] | Bradburn, M., Deeks, J., Berlin, J., and Russell, L., 2007, Much ado about nothing: A comparison of the performance of meta-analytical methods with rare events, Statistics in Medicine Journal, 26(1), pp.53-77. |
[25] | Higgins, J., Thompson, S., Deeks, J., and Altman, D, 2003, Measuring inconsistency in meta-analyses, BMJ, Vol.327, pp. 557-60. |
[26] | Ickovics, J. R., Hamburger, M.E., Vlahov. D., Schoenbaum, E. E., Schuman, P., Boland, R. J., and Moore, J., 2001, Mortality, CD4 cell count decline, and depressive symptoms among HIV- seropositive women longitudinal analysis from the HIV epidemiology. |
[27] | Cook, J. A., Grey, D., Burke, J., Cohen, M. H., Gurtman, A. C., Richardson, J. L., Wilson, T. E., Young, M. A., and Hessol, N. A., 2004, Depressive symptoms and AIDS- related mortality among a multisite cohort of HIV- positive women, American Journal of Public Health, 94(7), pp. 1133-40. |
[28] | Kilbourne, A., Justice, A., Rollman, B., McGinnis, K., and Rabeneck, L., 2002, Clinical importance of HIV and depressive symptoms among veterans with HIV infection, Journal of Gen. Intern. Med, Vol. 17, pp.512-20. |
[29] | Bengston, A., Pence, B., Crane, H., Christopoulos, K., and Heine, A., 2016, Depression increases the risk of mortality in a large cohort of HIV- infected adults, available at: www.croiconference.org/sites/default/files/posters -2016/920 (Accessed 19th February 2017). |
[30] | Page-Shaper, K., Delorenze, G., Satariano, W., and Winkelstein, W., 1996, Comorbidity and survival in HIV- infected men in the San Francisco men’s health survey, Elsevier Science Inc. Ann Epidemiol, Vol. 6, pp. 420-30. |
[31] | Villes, V., Spire, B., Lewden, C., Perronne, C., and Besnier, J., 2007, The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice, Antiviral Therapy Journal, Vol. 12, pp. 1067-74. |
[32] | Downs, S., and Black, N., 1998, The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions, Journal of Epidemiology and Community Health, 52, pp.377-84. Available at: http://dx.doi.org/10.1136/jech.52. 6. |